P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000936356.81008.a3 |
_version_ | 1827332261111922688 |
---|---|
author | I. Ntanasis-Stathopoulos M. Gavriatopoulou E. Eleutherakis-Papaiakovou P. Malandrakis V. Spiliopoulou R.E. Syrigou F. Theodorakakou D. Fotiou M. Migkou M. Roussou E. Kastritis M.A. Dimopoulos E. Terpos |
author_facet | I. Ntanasis-Stathopoulos M. Gavriatopoulou E. Eleutherakis-Papaiakovou P. Malandrakis V. Spiliopoulou R.E. Syrigou F. Theodorakakou D. Fotiou M. Migkou M. Roussou E. Kastritis M.A. Dimopoulos E. Terpos |
author_sort | I. Ntanasis-Stathopoulos |
collection | DOAJ |
first_indexed | 2024-03-07T16:56:27Z |
format | Article |
id | doaj.art-d4a76e86e2a140cb8b89c09d5eb94cef |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:56:27Z |
publishDate | 2023-05-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-d4a76e86e2a140cb8b89c09d5eb94cef2024-03-03T03:59:02ZengWileyHemaSphere2572-92412023-05-017S2424210.1097/01.HS9.0000936356.81008.a3202305002-00076P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMAI. Ntanasis-Stathopoulos0M. Gavriatopoulou1E. Eleutherakis-Papaiakovou2P. Malandrakis3V. Spiliopoulou4R.E. Syrigou5F. Theodorakakou6D. Fotiou7M. Migkou8M. Roussou9E. Kastritis10M.A. Dimopoulos11E. Terpos12Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greecehttp://journals.lww.com/10.1097/01.HS9.0000936356.81008.a3 |
spellingShingle | I. Ntanasis-Stathopoulos M. Gavriatopoulou E. Eleutherakis-Papaiakovou P. Malandrakis V. Spiliopoulou R.E. Syrigou F. Theodorakakou D. Fotiou M. Migkou M. Roussou E. Kastritis M.A. Dimopoulos E. Terpos P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA HemaSphere |
title | P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA |
title_full | P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA |
title_fullStr | P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA |
title_full_unstemmed | P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA |
title_short | P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA |
title_sort | p57 pre exposure prophylaxis for covid 19 with tixagevimab cilgavimab evusheld in patients with multiple myeloma |
url | http://journals.lww.com/10.1097/01.HS9.0000936356.81008.a3 |
work_keys_str_mv | AT intanasisstathopoulos p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT mgavriatopoulou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT eeleutherakispapaiakovou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT pmalandrakis p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT vspiliopoulou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT resyrigou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT ftheodorakakou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT dfotiou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT mmigkou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT mroussou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT ekastritis p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT madimopoulos p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma AT eterpos p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma |